June Lee

CIK 1696493 · EVP, Chief Development Officer · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.2K

Companies

4

Total Filings

28

Lifetime Open-Market Net

-$1.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNYA Director $0.71 $0 6 2026-05-29
ELDN Director 3,430 $3.57 $12.2K $0 5 2026-01-16
CinCor Pharma, Inc. (CINC) Delisted Director $29.06 $0 2 2023-02-24
MyoKardia, Inc. (MYOK) Delisted EVP, Chief Development Officer 18,793 -$1.36M 15 2019-10-29

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-09 MyoKardia, Inc. (MYOK) Delisted Tax (F) −1,100 -$48.5K EDGAR
2019-01-03 MyoKardia, Inc. (MYOK) Delisted Exer (M) +2,750 $0 EDGAR
2018-12-06 MyoKardia, Inc. (MYOK) Delisted Mixed +10,344 $378.3K EDGAR
2018-09-24 MyoKardia, Inc. (MYOK) Delisted Mixed -$255.9K EDGAR
2018-06-29 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2018-06-01 MyoKardia, Inc. (MYOK) Delisted Grant (A) +426 $14.1K EDGAR
2018-01-18 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2017-02-01 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.